|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
製品コード:D4048 Batch: D404801
Labetuzumab govitecan (IMMU-135) is a humanised anti-CEACAM5 (carcinoembryonic antigen-related cell adhesion molecule 5) antibody linked site-specifically to the active metabolite of irinotecan SN-38 via a proprietary linker. Labetuzumab govitecan can be used for research on colorectal cancer.
| CAS No. | 1469876-18-3 |
|---|---|
| Formulation | 1xPBS |
| ADC antiody | Labetuzumab |
| ADC linker | Lysine; a maleimide-type cleavable linker |
| ADC cytotoxin | SN-38 |
| Storage (From the date of receipt) |
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
| Shipping | Shipped under low temperature conditions |
| Purity | 99% |
| Protein concentration | 4.91 mg/ml |
| Endotoxin Level | <1EU/mg |
人間や獣医の診断であるか治療的な使用のためにでない。